![Helen Heslop](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Helen E.
Heslop is the founder of AlloVir, Inc. (2013) and Tikva Allocell Pte Ltd. (2023).
Dr. Heslop is currently the Director at Center For Cell & Gene Therapy and the Deputy Director at Dan L.
Duncan Comprehensive Cancer Center.
| Unternehmen | Position | Beginn |
|---|---|---|
Dan L. Duncan Comprehensive Cancer Center | Corporate Officer/Principal | - |
Center For Cell & Gene Therapy | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
The Leukemia & Lymphoma Society, Inc.
 The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization dedicated to funding research, education and support services for all blood cancers | Direktor/Vorstandsmitglied | - |
| ALLOVIRPAR | Gründer | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 4 |
|---|---|
The Leukemia & Lymphoma Society, Inc.
The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization dedicated to funding research, education and support services for all blood cancers | Commercial Services |
AlloVir, Inc.
 AlloVir, Inc. BiotechnologyHealth Technology Develops cellular immunotherapies for severe infections | Health Technology |
Center For Cell & Gene Therapy | |
Dan L. Duncan Comprehensive Cancer Center |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
Wählen Sie MarketScreener 
